Please login to the form below

Not currently logged in
Email:
Password:

New accounts: July

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period April to June 2005 inclusive.

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period April to June 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email nhobson@pmlive.com

  

Alchemy

Corporate

Corporate

Seven Stones

Boehringer Ingelheim

N/A

N/A

Dark Horse Agency

Chiron Biopharma Europe

N/A

N/A

Woolley Pau

Ferring

NPD

Urology

FCB Healthcare

Genzyme

Thyrogen

Oncology

Big Blue

Gilead Sciences

Emtriva

HIV

FCB HealthCare

Gilead Sciences

Truvada

HIV

FCB HealthCare

Gilead Sciences

Viread

HIV

FCB HealthCare

Gilead (International)

Corporate

HIV

FCB HealthCare

GlaxoSmithKline

New product

Neurology

Euro RSCG Life MSC

Janssen-Cilag

Lyrinel XL

Urinary incontinence

PBC Communications

Novartis

Zelnorm

IBS

The Medical Multimedia Company

Novo Nordisk

Diabetes insulin portfolio

Diabetes

Woolley Pau

Orion Pharma

Tridestra

HRT

Langland

Orion Pharma

Indivina

HRT

Langland

Pfizer

New product

Ophthalmology

The Medical Multimedia Company

Roche Diagnostics

Cobas

Hospital in-vitro diagnostics

PBC Communications

Roche (International)

NPD

Haematology

FCB HealthCare

Trinity-Chiesi Pharmaceuticals

New products

Respiratory portfolio

Swordfish Advertising

2nd September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....